Skip to search formSkip to main contentSkip to account menu

ostarine

Known as: ENOBOSARM, Propanamide, 3-(4-cyanophenoxy)-N-(4-cyano-3-(trifluoromethyl)phenyl)-2-hydroxy-2-methyl-, (2S)- 
A non-steroidal agent with anabolic activity. Selective androgen receptor modulator (SARM) GTx-024 is designed to work like testosterone, thus… 
National Institutes of Health

Related topics

Related topics

4 relations

Broader (1)

Anilides

Narrower (2)

GTx 024MK 2866
NCIt Antineoplastic Agent Terminology

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Evaluation of ostarine as a selective androgen receptor modulator in a rat model of postmenopausal osteoporosis
Selective androgen receptor modulators (SARMs) have shown beneficial effects on muscle wasting, general physical function and… 
2018
2018
LGD-4033, S-4 and MK-2866 – Testing for SARMs in hair: About 2 doping cases
2017
2017
Prevention of body weight loss and sarcopenia by a novel selective androgen receptor modulator in cancer cachexia models.
Cancer cachexia is a syndrome that impairs the quality of life and overall survival of patients, and thus the effectiveness of… 
2017
2017
Combined Androgen Administration and HDAC Inhibition in Experimental Cancer Cachexia
Background: Cancer cachexia impacts the majority of advanced cancer patients but no approved anti-cachexia therapeutic exits… 
2015
2015
Abstract P1-13-04: Enobosarm for the treatment of metastatic, estrogen and androgen receptor positive, breast cancer. Final results of the primary endpoint and current progression free survival
Background: Historically, androgens have been utilized for the treatment of breast cancer (BC) as the androgen receptor (AR) is… 
2014
2014
Enobosarm: A targeted therapy for metastatic, androgen receptor positive, breast cancer.
568 Background: The androgen receptor (AR) is the most highly expressed steroid receptor in breast cancer (BC) with 75-95% of… 
Review
2013
Review
2013
Highlights of mechanistic and therapeutic cachexia and sarcopenia research 2010 to 2012 and their relevance for cardiology
Sarcopenia and cachexia are significant medical problems with a high disease-related burden in cardiovascular illness. Muscle… 
2013
2013
Abstract P5-09-21: Selective androgen receptor modulators (SARMs): Enobosarm as targeted therapy for the treatment of androgen receptor-positive breast cancer
Background: The androgen receptor (AR) is the most highly expressed steroid receptor in breast cancer with 75-95% of estrogen… 
2013
2013
Applicability of routine analytical procedures to detect andarine and ostarine
The urinary excretion of selective androgen receptor modulators (SARMs) andarine and ostarine after controlled administration… 
2012
2012
Abstracts of the Cancer Cachexia Conference, Boston, USA, 21–23 September 2012
Abstracts of the Cancer Cachexia Conference, Boston, USA, 21–23 September 2012s of the Cancer Cachexia Conference, Boston, USA… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)